Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®

Clinical trial NCT02823951 · COMPLETED

Trial details

NCT number: NCT02823951
Sponsor: IMS HEALTH GmbH & Co. OHG
Status: COMPLETED
Study type: OBSERVATIONAL

Relapsing-remitting Multiple Sclerosis

Start date: 2016-02-01
Primary completion: 2017-04-01
Enrollment: 479

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.